Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $291.65 in the prior trading day, Cigna Group (NYSE: CI) closed at $296.98, up 1.83%. In other words, the price has increased by $1.83 from its previous closing price. On the day, 1.67 million shares were traded. CI stock price reached its highest trading level at $297.07 during the session, while it also had its lowest trading level at $288.1.
Ratios:
Our goal is to gain a better understanding of CI by taking a closer look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.77 whereas as Long-Term Debt/Eq ratio is at 0.66.
On June 26, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $400.
On May 30, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $388.Robert W. Baird initiated its Outperform rating on May 30, 2024, with a $388 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 15 ’25 when Jones Nicole S sold 28,526 shares for $300.00 per share. The transaction valued at 8,557,800 led to the insider holds 25,648 shares of the business.
Jones Nicole S bought 28,526 shares of CI for $8,557,800 on Aug 15 ’25. On Aug 12 ’25, another insider, Eder Noelle K, who serves as the Former Officer of the company, bought 35,711 shares for $275.06 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CI now has a Market Capitalization of 79272304640 and an Enterprise Value of 105114296320. As of this moment, Cigna’s Price-to-Earnings (P/E) ratio for their current fiscal year is 16.22, and their Forward P/E ratio for the next fiscal year is 8.99. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.50. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.30 while its Price-to-Book (P/B) ratio in mrq is 1.97. Its current Enterprise Value per Revenue stands at 0.401 whereas that against EBITDA is 9.214.
Stock Price History:
The Beta on a monthly basis for CI is 0.46, which has changed by -0.13087505 over the last 52 weeks, in comparison to a change of 0.16766965 over the same period for the S&P500. Over the past 52 weeks, CI has reached a high of $358.88, while it has fallen to a 52-week low of $256.89. The 50-Day Moving Average of the stock is 1.71%, while the 200-Day Moving Average is calculated to be -2.49%.
Shares Statistics:
The stock has traded on average 1.68M shares per day over the past 3-months and 1614790 shares per day over the last 10 days, according to various share statistics. A total of 266.60M shares are outstanding, with a floating share count of 262.94M. Insiders hold about 1.50% of the company’s shares, while institutions hold 89.84% stake in the company. Shares short for CI as of 1757894400 were 3261016 with a Short Ratio of 1.94, compared to 1755216000 on 3316471. Therefore, it implies a Short% of Shares Outstanding of 3261016 and a Short% of Float of 1.6199999999999999.
Dividends & Splits
In the trailing 12 months, CI’s forward annual dividend rate was 5.82, compared to 5.93 this year. Against a Trailing Annual Dividend Yield of 0.019955426. The stock’s 5-year Average Dividend Yield is 1.41. The current Payout Ratio is 46.19% for CI, which recently paid a dividend on 2025-09-04 with an ex-dividend date of 2025-09-04. Stock splits for the company last occurred on 2007-06-05 when the company split stock in a 3:1 ratio.
Earnings Estimates
. The current market rating for Cigna Group (CI) reflects the collective analysis of 22.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is $8.04, with high estimates of $8.47 and low estimates of $7.48.
Analysts are recommending an EPS of between $29.86 and $29.23 for the fiscal current year, implying an average EPS of $29.66. EPS for the following year is $33.03, with 24.0 analysts recommending between $34.0 and $32.16.
Revenue Estimates
14 analysts predict $66.4B in revenue for. The current quarter. It ranges from a high estimate of $68.59B to a low estimate of $63.38B. As of. The current estimate, Cigna Group’s year-ago sales were $63.69BFor the next quarter, 14 analysts are estimating revenue of $67.5B. There is a high estimate of $70.44B for the next quarter, whereas the lowest estimate is $64.5B.
A total of 18 analysts have provided revenue estimates for CI’s current fiscal year. The highest revenue estimate was $271.25B, while the lowest revenue estimate was $253.07B, resulting in an average revenue estimate of $263.49B. In the same quarter a year ago, actual revenue was $247.1BBased on 17 analysts’ estimates, the company’s revenue will be $274.51B in the next fiscal year. The high estimate is $289.14B and the low estimate is $264.89B.
